Publications

• Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
  J Clin Psychiatry Volume: 74 Page(s): 1010 - 1017
  10/01/2013 Authors: Clayton AH; Kornstein SG; Dunlop BW; Focht K; Musgnung J; Ramey T; Bao W; Ninan PT
• A meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sites.
  Neuropsychopharmacology Volume: 37 Page(s): 2830 - 2836
  12/01/2012 Authors: Dunlop BW; Thase ME; Wun C-C; Fayyad R; Guico-Pabia CJ; Musgnung J; Ninan PT
• The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder.
  J Psychiatr Res Volume: 46 Page(s): 1406 - 1413
  11/01/2012 Authors: Garlow SJ; Dunlop BW; Ninan PT; Nemeroff CB
• Recovery and subsequent recurrence in patients with recurrent major depressive disorder.
  J Psychiatr Res Volume: 46 Page(s): 708 - 715
  06/01/2012 Authors: Dunlop BW; Holland P; Bao W; Ninan PT; Keller MB
• Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder.
  J Psychiatr Res Volume: 45 Page(s): 96 - 103
  01/01/2011 Authors: Dunlop BW; Li T; Kornstein SG; Friedman ES; Rothschild AJ; Pedersen R; Ninan P; Keller M; Trivedi MH
• Correlation between patient and clinician assessments of depression severity in the PREVENT study.
  Psychiatry Res Volume: 177 Page(s): 177 - 183
  05/15/2010 Authors: Dunlop BW; Li T; Kornstein SG; Friedman ES; Rothschild AJ; Pedersen R; Ninan P; Keller M
• Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?
  J Affect Disord Volume: 119 Page(s): 181 - 185
  12/01/2009 Authors: Capuron L; Fornwalt FB; Knight BT; Harvey PD; Ninan PT; Miller AH
• Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
  Arch Gen Psychiatry Volume: 66 Page(s): 1178 - 1188
  11/01/2009 Authors: Kocsis JH; Gelenberg AJ; Rothbaum BO; Klein DN; Trivedi MH; Manber R; Keller MB; Leon AC; Wisniewski SR; Arnow BA
• A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression.
  J Psychiatr Res Volume: 43 Page(s): 205 - 214
  01/01/2009 Authors: Keitner GI; Garlow SJ; Ryan CE; Ninan PT; Solomon DA; Nemeroff CB; Keller MB
• Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.
  Int Clin Psychopharmacol Volume: 23 Page(s): 357 - 363
  11/01/2008 Authors: Kornstein SG; Kocsis JH; Ahmed S; Thase M; Friedman ES; Dunlop BW; Yan B; Pedersen R; Ninan PT; Li T
• The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies.
  J Clin Psychiatry Volume: 69 Page(s): 1513 - 1528
  10/01/2008 Authors: Gelenberg AJ; Thase ME; Meyer RE; Goodwin FK; Katz MM; Kraemer HC; Potter WZ; Shelton RC; Fava M; Khan A